Skip to main content
Cellromax Science Co., Ltd. logo

Cellromax Science Co., Ltd. — Investor Relations & Filings

Ticker · 471820 ISIN · KR7471820001 KO Manufacturing
Open in API
Filings indexed 90 across all filing types
Latest filing 2026-03-13 Proxy Solicitation & In…
Country KR South Korea
Listing KO 471820

About Cellromax Science Co., Ltd.

https://www.cellromax.kr/

Cellromax Science Co., Ltd. is a company specializing in the research, development, and manufacturing of health-related products. Its portfolio is centered on three key areas: health functional foods, derma-cosmetics, and over-the-counter (OTC) pharmaceuticals. The company leverages scientific research and high-quality, naturally derived ingredients to create unique and effective products. Its development philosophy emphasizes optimized formulas and specialized prescriptions designed to support consumer health, skin vitality, and overall well-being.

Recent filings

Filing Released Lang Actions
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal notice of a General Meeting (주주총회소집결의), which outlines the date, location, and agenda items (such as financial statement approval, director appointments, and dividend proposals) for an upcoming shareholder meeting. This type of document is a standard proxy solicitation material used to inform shareholders of the meeting details and the matters to be voted upon, fitting the definition of Proxy Solicitation & Information Statement (PSI).
2026-03-13 Korean
중간(분기)배당을위한주주명부폐쇄(기준일)결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement regarding the determination of a record date for quarterly dividend distribution. It specifies the record date (2026-03-31) and the purpose (confirming shareholders for quarterly dividends). This falls under the category of dividend-related announcements.
2026-03-13 Korean
주식소각결정
Share Issue/Capital Change Classification · 95% confidence The document is an official announcement regarding a 'Decision to Cancel Shares' (주식소각 결정) by Cellromax Science. It details the number of shares to be cancelled, the method (cancellation of treasury shares), and the board resolution date. This falls under capital structure changes related to share cancellation, which is best classified as a share capital change or transaction in own shares. Given the specific nature of cancelling treasury shares, 'POS' (Transaction in Own Shares) is the most accurate classification.
2026-02-13 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Management Reports Classification · 95% confidence The document is a regulatory filing from Cellromax Science regarding a significant change in revenue or profit/loss structure (exceeding 15% for large corporations or 30% for others). This is a standard financial disclosure required by the Korea Exchange (KRX) when financial results deviate significantly from the previous period. It provides key financial highlights (revenue, operating profit, net income) and explains the reasons for the change. It is not a full annual report (10-K) or an interim report (IR), but rather an initial earnings announcement (Earnings Release) focusing on the material change in financial structure.
2026-02-13 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed in South Korea. This type of filing is required under the Capital Markets Act when a person or entity acquires a significant stake (typically 5% or more) in a listed company, often referred to as a '5% rule' filing. In the provided taxonomy, this corresponds to a 'Major Shareholding Notification'.
2026-01-27 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (증권선물위원회) and the Korea Exchange. This type of filing is specifically used to report insider shareholdings and changes in ownership by company directors or major shareholders. In the provided taxonomy, this corresponds to 'Director's Dealing' (DIRS), which covers personal share transactions and ownership status reports by company insiders.
2026-01-27 Korean

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.